On Friday, Applied Therapeutics Inc (NASDAQ: APLT) opened lower -3.37% from the last session, before settling in for the closing price of $5.34. Price fluctuations for APLT have ranged from $0.77 to $9.39 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 52.74% at the time writing. With a float of $82.80 million, this company’s outstanding shares have now reached $84.87 million.
In an organization with 25 employees, it is important to assess its efficiency.
Applied Therapeutics Inc (APLT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Applied Therapeutics Inc is 21.80%, while institutional ownership is 56.10%. The most recent insider transaction that took place on Mar 14 ’24, was worth 1,717,108. In this transaction President and CEO of this company sold 318,573 shares at a rate of $5.39, taking the stock ownership to the 3,817,814 shares. Before that another transaction happened on Mar 14 ’24, when Company’s Chief Medical Officer sold 110,804 for $5.39, making the entire transaction worth $597,234. This insider now owns 1,031,537 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 9.20 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.74% per share during the next fiscal year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Check out the current performance indicators for Applied Therapeutics Inc (APLT). In the past quarter, the stock posted a quick ratio of 0.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 51.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.57 million. That was inferior than the volume of 2.04 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 8.01%. Additionally, its Average True Range was 0.49.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 44.34%, which indicates a significant increase from 5.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.23% in the past 14 days, which was lower than the 145.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.46, while its 200-day Moving Average is $2.98. However, in the short run, Applied Therapeutics Inc’s stock first resistance to watch stands at $5.36. Second resistance stands at $5.57. The third major resistance level sits at $5.72. If the price goes on to break the first support level at $5.00, it is likely to go to the next support level at $4.85. Assuming the price breaks the second support level, the third support level stands at $4.64.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
There are currently 105,887K shares outstanding in the company with a market cap of 546.39 million. Presently, the company’s annual sales total 9,990 K according to its annual income of -119,760 K. Last quarter, the company’s sales amounted to -670 K and its income totaled -37,680 K.
